Search Results - "Michaux, JL"

Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey by Lecouvet, Frédéric E., Malghem, Jacques, Michaux, Lucienne, Maldague, Baudouin, Ferrant, Augustin, Michaux, Jean‐Louis, Vande Berg, Bruno C.

“…In an attempt to compare the sensitivity of bone radiographs and bone marrow magnetic resonance (MR) imaging for bone lesion detection in patients with stage…”
Get full text

Cytogenetic abnormalities in adult acute lymphoblastic leukemia : Correlations with hematologic findings and outcome. A collaborative study of the Groupe Français de Cytogénétique Hématologique

Get full text

Clinical and Molecular Characterization of a Rare Syndrome of Acute Promyelocytic Leukemia Associated With Translocation (11; 17) by Licht, Jonathan D., Chomienne, Christine, Goy, Andre, Chen, Alex, Scott, Amy A., Head, David R., Michaux, Jean Louis, Wu, Yu, DeBlasio, Anthony, Miller, Wilson H., Zelenetz, Andrew D., Willman, Cheryl L., Chen, Zhu, Chen, Sai-Juan, Zelent, A., Macintyre, Elizabeth, Veil, Agnes, Cortes, Jorge, Kantarjian, Hagop, Waxman, Samuel

“…Analysis of a variant translocation t(11; 17) in a case of acute promyelocytic leukemia (APL) led to discovery of a novel zinc finger gene, PLZF, fused to the…”
Get full text

Pharmacokinetics and Safety of a 7-Day Administration of Intravenous Itraconazole followed by a 14-Day Administration of Itraconazole Oral Solution in Patients with Hematologic Malignancy by BOOGAERTS, Marc A, MAERTENS, Johan, VAN DER GEEST, Ronald, BOSLY, Andre, MICHAUX, Jean-Louis, VAN HOOF, Achiel, CLEEREN, Myriam, WOSTENBORGHS, Robert, DE BEULE, Karel

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging by Lecouvet, F E, Vande Berg, B C, Michaux, L, Malghem, J, Maldague, B E, Jamart, J, Ferrant, A, Michaux, J L

“…To determine the clinical and prognostic value of spinal bone marrow magnetic resonance (MR) imaging in stage III multiple myeloma. In 80 patients with…”
Get more information

On the origin of variable structures in the winds of hot luminous stars by Michaux, Yannick J. L., Moffat, Anthony F. J., Chené, André-Nicolas, St-Louis, Nicole

“…Examination of the temporal variability properties of several strong optical recombination lines in a large sample of Galactic Wolf-Rayet (WR) stars reveals…”
Get full text

A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group by Wattel, E, Guerci, A, Hecquet, B, Economopoulos, T, Copplestone, A, Mahé, B, Couteaux, M E, Resegotti, L, Voglova, V, Foussard, C, Pegourié, B, Michaux, J L, Deconinck, E, Stoppa, A M, Mufti, G, Oscier, D, Fenaux, P

“…We performed a randomized study of hydroxyurea (HY) versus VP16 in advanced chronic myelomonocytic leukemia (CMML) patients with CMML (according to…”
Get full text

Philadelphia-Negative (Ph-) Chronic Myeloid Leukemia (CML): Comparison With Ph+ CML and Chronic Myelomonocytic Leukemia by Martiat, P., Michaux, J.L., Rodhain, J.

“…To better understand the Philadelphia-negative (Ph-) chronic myeloid leukemia (CML) and its relationships with Philadelphia-positive (Ph+) CML and chronic…”
Get full text

Stage I multiple myeloma: value of MR imaging of the bone marrow in the determination of prognosis by Van de Berg, B C, Lecouvet, F E, Michaux, L, Labaisse, M, Malghem, J, Jamart, J, Maldague, B E, Ferrant, A, Michaux, J L

“…To determine the prognostic value of bone marrow findings at magnetic resonance (MR) imaging in patients with stage I multiple myeloma. In 24 patients with…”
Get more information

Phase I/II study of 2-chloro-2'-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma by VAN DEN NESTE, E, LOUVIAUX, I, STRAETMANS, N, COCHE, E, VENET, C, DUPREZ, T, FERRANT, A, MICHAUX, J. L, DELANNOY, A, MICHAUX, L, SONET, A, BOSLY, A, DOYEN, C, MINEUR, P, ANDRE, M

“…Because of their substantial in vitro synergy, we conducted a dose-escalation study of cyclophosphamide (CP) added to 2-chloro-2'-deoxyadenosine (CdA) in…”
Get full text

Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria by Hernandez, J M, Mecucci, C, Criel, A, Meeus, P, Michaux, I, Van Hoof, A, Verhoef, G, Louwagie, A, Scheiff, J M, Michaux, J L

“…609 patients with B cell chronic lymphoproliferative disorder were studied with the primary aim of analyzing the cytogenetic profile of B cell chronic…”
Get more information

Long-Term Follow-up of Residual Disease in Acute Lymphoblastic Leukemia Patients in Complete Remission Using Clonogeneic IgH Probes and the Polymerase Chain Reaction by Nizet, Y., Van Daele, S., Lewalle, P., Vaerman, J.L., Philippe, M., Vermylen, C., Cornu, G., Ferrant, A., Michaux, J.L., Martiat, P.

“…We sequentially studied bone marrow (BM) samples of 25 patients in complete remission of an acute lymphoblastic leukemia (ALL) using a simplified polymerase…”
Get full text

Cladribine for Waldenström's macroglobulinaemia by Delannoy, A., Van Den Neste, E., Michaux, J. L., Bosly, A., Ferrant, A.

Get full text

Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome? by Michaux, J L, Martiat, P

“…Chronic myelomonocytic leukaemia (CMML), a disorder belonging to the group of myelodysplastic syndromes, has a number of peculiar features which raise the…”
Get more information

Cytogenetic Profile of Minimally Differentiated (FAB MO) Acute Myeloid Leukemia: Correlation with Clinicobiologic Findings by Cuneo, Antonio, Ferrant, Augustin, Michaux, Jean Louis, Boogaerts, Marc, Demuynck, Hilde, Orshoven, Angeline Van, Criel, Arnold, Stul, Michel, Cin, Paola Dal, Hernandez, Jesus, Chatelain, Bernard, Doyen, Chantal, Louwagie, Andries, Castoldi, Gianluigi, Cassiman, Jean-Jacques, Berghe, Herman Van Den

“…Cytogenetic data were studied in 26 patients with de novo acute myeloid leukemia (AMD with minimal myeloid differentiation, corresponding to the MO subtype of…”
Get full text

Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology by Goasguen, Jean E, Zandecki, Marc, Mathiot, Claire, Scheiff, Jean-Marie, Bizet, Marie, Ly-Sunnaram, Béatrice, Grosbois, Bernard, Monconduit, Matthieu, Michaux, Jean-Louis, Facon, Thierry

“…The relationship between plasmablastic cells and outcome in multiple myeloma (MM) has been established for nearly 15 years. But the assessment of these cells…”
Get full text

Philadelphia chromosome-positive acute myeloid leukemia: cytoimmunologic and cytogenetic features by Cuneo, A, Ferrant, A, Michaux, JL, Demuynck, H, Boogaerts, M, Louwagie, A, Doyen, C, Stul, M, Cassiman, JJ, Dal Cin, P, Castoldi, G, Van den Berghe, H

“…Institute of Hematology, University of Ferrara, Italy. BACKGROUND: Little is known about the morphological and clinical features of the minority of acute…”
Get full text

Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient by Guidez, F, Huang, W, Tong, J H, Dubois, C, Balitrand, N, Waxman, S, Michaux, J L, Martiat, P, Degos, L, Chen, Z

“…All-trans retinoic acid (ATRA) is a potent inducer of differentiation and cell death in malignant cells. Its effect is known to be mediated through binding to…”
Get more information

Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2‐chloro‐2′‐deoxyadenosine by Van Den Neste, E., Louviaux, I., Michaux, J.‐L., Delannoy, A., Michaux, L., Hagemeijer, A., Scheiff, J.‐M., Bosly, A., Straetmans, N., Ferrant, A.

“…A few cases of secondary neoplasms occurring after treatment with 2‐chloro‐2′‐deoxyadenosine (2CdA) have been reported, mostly in patients previously exposed…”
Get full text

A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission by Filleul, B, Delannoy, A, Ferrant, A, Zenebergh, A, Van Daele, S, Bosly, A, Doyen, C, Mineur, P, Glorieux, P, Driesschaert, P

“…The nucleoside analog 2-chlorodeoxyadenosine (2-CdA) has recently emerged as a most promising treatment for hair-cell leukemia (HCL). The response rates are…”
Get more information